+Compare
ARAY
Stock ticker:
NASDAQ
AS OF
Jun 30, 09:57 AM (EDT)
Price
$1.98
Change
-$0.04 (-1.98%)
Capitalization
187.46M

ARAY Price Prediction, Accuray AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 29, 2022

ARAY in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 15, 2022

ARAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 43 cases where ARAY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARAY's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where ARAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 29, 2022. You may want to consider a long position or call options on ARAY as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARAY just turned positive on June 22, 2022. Looking at past instances where ARAY's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ARAY advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARAY entered a downward trend on June 22, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.632) is normal, around the industry mean (7.078). P/E Ratio (0.000) is within average values for comparable stocks, (92.828). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.135). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.430) is also within normal values, averaging (92.060).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ARAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

ARAY is expected to report earnings to rise 483.00% to -5 cents per share on August 18

Accuray ARAY Stock Earnings Reports
Q2'22
Est.
$-0.06
Q1'22
Beat
by $0.05
Q4'21
Est.
$0.00
Q3'21
Beat
by $0.03
Q2'21
Missed
by $0.10
The last earnings report on April 27 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 64.21K shares outstanding, the current market capitalization sits at 187.46M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.65B. The market cap for tickers in the group ranges from 775 to 3.78T. MKYSF holds the highest valuation in this group at 3.78T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -27%. NRCD experienced the highest price growth at 2,122%, while SSSGY experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 61
SMR Rating: 69
Profit Risk Rating: 83
Seasonality Score: 14 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a manufacturer of medical equipment

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1310 Chesapeake Terrace
Phone
+1 408 716-4600
Employees
932
Web
https://www.accuray.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EARFX21.730.09
+0.42%
First Eagle Fund of America R3
MUSNX9.010.01
+0.11%
Mirova US Sustainable Equity N
SUTCX16.03-0.03
-0.19%
AB Sustainable US Thematic C
EPSZX18.75-0.06
-0.32%
MainStay Epoch Global Equity Yield R2
PWJDX23.15-0.08
-0.34%
PGIM Jennison International Opps R4

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with VRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then VRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+1.00%
VRAY - ARAY
53%
Loosely correlated
-0.35%
LUNG - ARAY
52%
Loosely correlated
-2.31%
ABMD - ARAY
52%
Loosely correlated
+2.97%
PSNL - ARAY
52%
Loosely correlated
-5.16%
CERS - ARAY
51%
Loosely correlated
+0.38%
More